- Home
- Sponsor
-
Insulet - Omnipod
- AGCO
- Accelerate Wind
- Adsys Controls
- Aerodyne/Autodesk
- Air Partners / Aerodyne Research
- Amazon Robotics
- Analogic
- Apportable
- Ariens
- Army Research Laboratory
- Arthur G Russell
- Auris Surgical Robotics
- Autodesk
- Avalanche Energy
- Bill & Melinda Gates Foundation
- Blue Origin
- Boeing
- Bose
- Boston Scientific
- Boston University Wheelock Institute for the Science of Education
- Brandeis University Rosbash Lab
- Brandeis University/ NSF
- CUAHSI
- CUAHSI
- Care.com
- Dassault Systemes
- DePuy Synthes Mitek Sports Medicine
- Draper
- Fidelity Center for Applied Technology
- Fidelity Labs
- Ford Motor Company
- GE Healthcare
- Giner Labs, Inc.
- Harley-Davidson
- Hutchinson/Barry Controls
- IBM
- Indico
- Insulet - Omnipod
- Intuit
- Iron Mountain
- Ivani
- Johnson & Johnson
- La Fondation Dassault Systèmes / MBARI
- Lexmark
- Limbs, Autodesk
- LineVision
- Locus Robotics
- MIT Lincoln Lab
- Mangata Networks
- Massachusetts Department of Early Education and Care
- Microsoft New England Research & Development (NERD)
- Microsoft
- Mitsubishi Electric
- Moderna
- New Balance
- Onshape
- Orica Mining Services
- OsComp Systems
- Parietal Systems
- Pfizer
- Raytheon
- Rockwell Automation
- Santos Family Foundation
- Santos Family Foundation/Volpe National Transportation Center
- Scientific Systems
- Semtech
- Sonos
- SpaceX
- SparkCharge
- TE Connectivity
- Tata Motors & Autodesk
- Toyota
- TripAdvisor
- Twilio
- Watts Water Technologies, Inc.
- athenahealth
Insulet - Omnipod

Insulet is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. Omnipod provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.